Garry Arthur Neil, CEO and Chairman of the Board at Avalo Therapeutics, Inc. (AVTX), bought 4,000 shares at $3.42 ($14K) on 2023-06-09, disclosed to the SEC on 2023-06-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CERC | BUY | 2021-06-14 | $8K | — | Filing → |
| CERC | BUY | 2020-12-14 | $8K | — | Filing → |
| CERC | BUY | 2020-06-11 | $4K | — | Filing → |